Velsera, a healthcare technology company offering a universal software platform to connect clinical care with discovery, is proud to be holding its inaugural Diagnostics & Discovery Summit this week in Boston. The summit’s two-day lineup of notable speakers will highlight advances and areas of collaboration in precision medicine across R&D, clinical diagnostics, healthcare technology, assay development, patient registries and public programs.
Velsera convened this program to showcase the potential power of a connected ecosystem of diverse data, insights and expertise. The summit aims to inspire and engage participants, offering a platform for networking, knowledge exchange and fostering of new ideas. Participants share Velsera’s interest in accelerating target identification, new therapy development, clinical trials optimization and ‘omics-driven diagnostics and decision support at scale.
Featured topics include:
- AI and machine learning (ML) strategies for precision medicine
- Bridging the gap between discovery and diagnostics
- The multi-omic future of precision medicine
- What universal germline testing means for optimized care
- The future of biomarker-driven clinical trials
“We are excited to bring together such a distinguished lineup of speakers and thought-provoking panels for this year’s summit, as part of our mission to usher in a new era of precision medicine,” said Gavin Nichols, CEO of Velsera. “Attendees can expect a dynamic and stimulating experience, as we explore a wide range of intriguing topics and facilitate meaningful conversations.”
The spotlight session on AI and machine learning will be presented by Meghan M. Dierks, MD, FACS, chief data officer at Komodo Health.
“I am honored to be a part of Velsera’s Diagnostics & Discovery Summit, discussing how AI and machine learning is driving some of the most exciting areas of progress in healthcare,” said Dr. Dierks. “The use of AI and ML in healthcare has accelerated substantially in recent years, particularly in developing highly targeted therapeutics and diagnostics. We are reaching an inflection point, where the impact of AI and ML on direct patient care and our ability to deliver on the promises of precision medicine will be substantial. This is an exciting time to be part of this field, and I look forward to hearing from other industry leaders at the event.”
The summit will take place Tuesday, May 16, and Wednesday, May 17, at the Mandarin Oriental Hotel in Boston. To learn more, visit www.velsera-dds.com, and while registration is closed, you can follow along with the event’s updates and announcements on Velsera’s LinkedIn and Twitter accounts.
About Velsera
Velsera is the precision engine company. Launched in January 2023, we connect healthcare and life sciences to reveal the true promise of precision medicine – a continuous flow of knowledge among researchers, scientists and clinicians around the world, creating insights that radically improve human health. For more information, visit www.velsera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005269/en/